The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study evaluating preliminary safety, pharmacokinetic and pharmacodynamic of pemigatinib in Chinese patients with advanced malignancy.
 
Yi Ba
No Relationships to Disclose
 
Ting Deng
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Le Zhang
No Relationships to Disclose
 
Guiying Bai
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Aizong Shen
No Relationships to Disclose
 
Xinghua Han
No Relationships to Disclose
 
Zhaoyi Yang
No Relationships to Disclose
 
Lian Cao
Employment - Innovent Biologics
 
Yang Luo
Employment - Innovent Biologics
 
Yan Wang
Employment - Innovent Biologics
 
Hui Zhou
Employment - Innovent Biologics